Inflacam Oral Suspension For Dogs

Inflacam Oral Suspension For Dogs
1.5mg/ml » 15ml Bottle

Images are for illustration purposes only. Packaging may change from time to time and images on our website may or may not be updated.

  • 1.5mg/ml » 15ml Bottle £9.06
  • 1.5mg/ml » 42ml Bottle £15.67
  • 1.5mg/ml » 100ml Bottle £20.93

Selection of 3 products from

£9.06 to £20.93


Inflacam Oral Suspension for Dogs 1.5mg/ml is for treatment of inflammation and pain in chronic musculo-skeletal disorders in dogs.

Inflacam 1.5mg/mL oral suspension for dogs

Species: Dogs

Therapeutic Indication: Pharmaceuticals: Anti-inflammatory preparations: Oral: Other NSAIDs

Active ingredient: Meloxicam

Product: Inflacam 1.5mg/mL oral suspension for dogs

Product index: Inflacam 1.5mg/mL oral suspension for dogs

Qualitative and quantitative composition

One ml contains:

Active substance: Meloxicam 1.5 mg

Excipient: Sodium benzoate 5 mg. For the full list of excipients, see section 6.1

Pharmaceutical form

Oral suspension. A yellow coloured suspension.

Clinical particulars

Target species


Indications for use

Alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders in dogs.


Do not use in pregnant or lactating animals.

Do not use in dogs suffering from gastrointestinal disorders such as irritation and haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic disorders.

Do not use in case of hypersensitivity to the active substance or to any of the excipients.

Do not use in dogs less than 6 weeks of age.

Special warnings for each target species


Special precautions for use

Special precautions for use in animals

Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is a potential risk of renal toxicity.

Special precautions to be taken by the person administering the veterinary medicinal product to animals

People with known hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs) should avoid contact with the veterinary medicinal product.

In case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the physician.

Adverse reactions

Typical adverse reactions of NSAIDs such as loss of appetite, vomiting, diarrhoea, faecal occult blood, lethargy and renal failure have occasionally been reported. In very rare cases haemorrhagic diarrhoea, haematemesis, gastrointestinal ulceration and elevated liver enzymes have been reported.

These side effects occur generally within the first treatment week and are in most cases transient and disappear following termination of the treatment but in very rare cases may be serious or fatal.

If adverse reactions occur, treatment should be discontinued and the advice of a veterinarian should be sought.

Use during pregnancy, lactation or lay

The safety of the veterinary medicinal product has not been established during pregnancy and lactation (see section 4.3).


Other NSAIDs, diuretics, anticoagulants, aminoglycoside antibiotics and substances with high protein binding may compete for binding and thus lead to toxic effects. Inflacam must not be administered in conjunction with other NSAIDs or glucocorticosteroids.

Pre-treatment with anti-inflammatory substances may result in additional or increased adverse effects and accordingly a treatment-free period with such veterinary medicinal products should be observed for at least 24 hours before commencement of treatment. The treatment-free period, however, should take into account the pharmacokinetic properties of the veterinary products used previously.

Amounts to be administered and administration route

Initial treatment is a single dose of 0.2 mg meloxicam/kg body weight on the first day. Treatment is to be continued once daily by oral administration (at 24-hour intervals) at a maintenance dose of 0.1 mg meloxicam/kg body weight.

For longer term treatment, once clinical response has been observed (after ≥ 4 days), the dose of Inflacam can be adjusted to the lowest effective individual dose reflecting that the degree of pain and inflammation associated with chronic musculo-skeletal disorders may vary over time.

Particular care should be taken with regard to the accuracy of dosing.

Shake well before use. To be administered orally either mixed with food or directly into the mouth.

The suspension can be given using the Inflacam measuring syringe provided in the package. The syringe fits onto the bottle and has a kg-body weight scale which corresponds to the maintenance dose (i.e. 0.1 mg meloxicam/kg body weight). Thus for initiation of the therapy on the first day, twice the maintenance volume will be required.

A clinical response is normally seen within 3–4 days. Treatment should be discontinued after 10 days at the latest if no clinical improvement is apparent.

Avoid introduction of contamination during use.


In case of overdose symptomatic treatment should be initiated.

Withdrawal periods

Not applicable

Pharmacological particulars

Pharmacotherapeutic group: Anti-inflammatory and Anti-rheumatic products, Non-steroids.

ATCvet code: QM01AC06.

Pharmacodynamic properties

Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam class which acts by inhibition of prostaglandin synthesis, thereby exerting anti-inflammatory, analgesic, anti-exudative and antipyretic effects. It reduces leukocyte infiltration into the inflamed tissue. To a minor extent it also inhibits collagen-induced thrombocyte aggregation. In vitro and in vivo studies demonstrated that meloxicam inhibits cyclooxygenase-2 (COX-2) to a greater extent than cyclooxygenase-1 (COX-1).

Pharmacokinetic properties


Meloxicam is completely absorbed following oral administration and maximal plasma concentrations are obtained after approximately 7.5 hours. When the product is used according to the recommended dosage regime, steady state concentrations of meloxicam in plasma are reached on the second day of treatment.


There is a linear relationship between the dose administered and plasma concentration observed in the therapeutic dose range. Approximately 97% of meloxicam is bound to plasma proteins. The volume of distribution is 0.3 l/kg.


Meloxicam is predominantly found in plasma and is also a major biliary excretion product whereas urine contains only traces of the parent compound. Meloxicam is metabolised to an alcohol, an acid derivative and to several polar metabolites. All major metabolites have been shown to be pharmacologically inactive.


Meloxicam is eliminated with a half-life of 24 hours. Approximately 75% of the administered dose is eliminated via faeces and the remainder via urine.

Pharmaceutical particulars


Saccharin sodium

Sodium carboxyl methyl cellulose

Colloidal silicon dioxide

Citric acid monohydrate

Sorbitol solution

Disodium hydrogen-phosphate dodecahydrate

Sodium benzoate

Honey flavour

Purified water.

Major incompatibilities

None known

Shelf life

Shelf life of the veterinary medicinal product as packaged for sale: 2 years.

Shelf life after first opening the immediate packaging: 6 months.

Special precautions for storage

This veterinary medicinal product does not require any special storage conditions.

Immediate packaging

15 ml HDPE bottle with a tamper resistant child proof closure or 42, 100 or 200 ml polyethylene terephthalate (PET) bottle with a tamper resistant child proof closure and two polypropylene measuring syringes: one for small dogs (up to 20 kg) and one for bigger dogs (up to 60 kg).

Not all pack sizes may be marketed.


Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.

Marketing Authorisation Holder (if different from distributor)

Chanelle Pharmaceuticals Manufacturing Ltd., Loughrea, Co. Galway, Ireland.

Marketing Authorisation Number

EU/2/11/134/001 15 ml

EU/2/11/134/002 42 ml

EU/2/11/134/003 100 ml

EU/2/11/134/004 200 ml

Legal category

Legal category: POM-V


GTIN description: Inflacam 1.5mg/ml Oral Suspension for Dogs 15ml


GTIN description: Inflacam 1.5mg/ml Oral Suspension for Dogs 42ml


GTIN description: Inflacam 1.5mg/ml Oral Suspension for Dogs 100ml


Need help or advice? Contact us:

All prices include VAT where applicable.

Medication Datasheets

Reviews (13)

Summary of Reviews for Inflacam Oral Suspension For Dogs

Overall 4
Ease Of Use
Value For Money
Absence Of Side Effects
13 out of 13 (100%) customers would recommend this product.
5 stars (6 reviews)
4 stars (7 reviews)
3 stars (0 reviews)
2 stars (0 reviews)
1 stars (0 reviews)

Only verified purchasers of this product can leave a review.

55 Used for a good while now.
Verified Purchase

By on 26 October 2023

Trudie is now 14 years old and has struggled with walking/getting up on her feet for some time. She still struggles with this product but would really suffer a lot more without.

Customer recommends this product

45 Great Service
Verified Purchase

By on 14 February 2023

The product is as prescribed by my Vet for arthritis and has been very effective in increasing mobility for our ageing pet.

Customer recommends this product

45 Fast delivery. Easy to order and send prescription details
Verified Purchase

By on 12 June 2022

Good product

Customer recommends this product

55 Effective treatment.
Verified Purchase

By on 27 March 2022

Easy to administer and very effective.

Customer recommends this product

45 Inflacam
Verified Purchase

By on 14 March 2022

Product as prescribed by Vet

Customer recommends this product

Page 1 of 3

Next Page

Q & A

Below are some recent questions we've received regarding Inflacam Oral Suspension For Dogs, including answers from our team.

29 July 2020 at 7:30pm

Infacalm dose for French bulldog


hi how much should my frenchy have of infacalm ? He weighs roughly 15kg. I have read the leaflet but am still bit unsure

  • VioVet Staff

Inflacam should come with a measuring syringe that has kg measurements on it. The standard dose is taken by drawing the medication into the syringe up to your dog's weight in kg as inscribed on the syringe. This is usually done at most once daily. I would seek your vet's advice for specific doseages however.

Delivery Information